Significant Ownership of L.P. Versant Vantage II

Location
San Francisco, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by L.P. Versant Vantage II.

Notify me when L.P. Versant Vantage II files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of L.P. Versant Vantage II

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TPST Tempest Therapeutics, Inc. Common Stock, par value $0.001 per share 3.7% $1,108,210 -$13,298,570 162,972 -92% Versant Vantage II, L.P. 11 Aug 2025

Schedules 13D/G Reported by L.P. Versant Vantage II:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.